BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 759229)

  • 1. Clinical problems of resistance to cancer chemotherapeutic agents.
    Lane M
    Fed Proc; 1979 Jan; 38(1):103-7. PubMed ID: 759229
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resistance to chemotherapeutic agents in the treatment of cancer. Emphasizing the multiresistant phenotype].
    Holte H
    Tidsskr Nor Laegeforen; 1991 Aug; 111(19):2423-7. PubMed ID: 1926080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic failure of antineoplastic agents. Extracellular and cellular causes].
    Hofsli E
    Tidsskr Nor Laegeforen; 1991 Jan; 111(1):37-40. PubMed ID: 2000585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy update.
    Miaskowski C
    Nurs Clin North Am; 1991 Jun; 26(2):331-9. PubMed ID: 2047287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance in cancer therapy.
    Cancer Treat Res; 1989; 48():1-203. PubMed ID: 2577132
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug resistance and a strategy to eradicate resistant malignant cells].
    Shimoyama M
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1280-2. PubMed ID: 2730026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New test reveals extreme drug resistance in many cancer patients.
    Oncology (Williston Park); 1990 May; 4(5):76. PubMed ID: 2143412
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of tumor cell resistance to cancer chemotherapeutic drugs.
    Hansson J
    Eur J Surg Suppl; 1991 May; (561):35-44. PubMed ID: 1720047
    [No Abstract]   [Full Text] [Related]  

  • 9. Overcoming drug resistance in the treatment of cancer.
    Am Pharm; 1984 Apr; NS24(4):12-4. PubMed ID: 6720567
    [No Abstract]   [Full Text] [Related]  

  • 10. The reversal of multidrug resistance in cancer (review).
    Kellen JA
    Anticancer Res; 1993; 13(4):959-61. PubMed ID: 8352566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer chemotherapy. Progress in understanding multidrug resistance.
    Stark GR
    Nature; 1986 Dec 4-10; 324(6096):407-8. PubMed ID: 2878367
    [No Abstract]   [Full Text] [Related]  

  • 12. [Resistance and resistances].
    Cappelaere P
    Bull Cancer; 1994 Dec; 81 Suppl 2():115s-117s. PubMed ID: 7727857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multidrug resistance phenotype in human cancer.
    Cordon-Cardo C; O'Brien JP
    Important Adv Oncol; 1991; ():19-38. PubMed ID: 1678363
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer chemotherapy.
    McElwain TJ
    Clin Oncol; 1980 Mar; 6(1):85-6. PubMed ID: 7371238
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple drug resistance in cancer therapy.
    Schneider E; Cowan KH
    Med J Aust; 1994 Mar; 160(6):371-3. PubMed ID: 7907772
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer chemotherapy 1990.
    Bagshawe KD
    Trans Med Soc Lond; 1989-1990; 106():42-50. PubMed ID: 2562620
    [No Abstract]   [Full Text] [Related]  

  • 17. Mosaicism induced by gene insertion as a means of improving chemotherapeutic selectivity.
    Moolten FL
    Crit Rev Immunol; 1990; 10(3):203-33. PubMed ID: 2085408
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological aspects of resistance to antineoplastic chemotherapy].
    D'Alessandro N
    Clin Ter; 1991 Jul; 138(1):37-44. PubMed ID: 1834399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.
    Shah MA; Schwartz GK
    Clin Cancer Res; 2001 Aug; 7(8):2168-81. PubMed ID: 11489790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From the research laboratory to the clinical laboratory: reflections on the transfer of technology about drug resistance].
    Favre R
    Bull Cancer; 1994 Dec; 81 Suppl 2():112s-114s. PubMed ID: 7727856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.